John E. (Jack) Jr. Bailey, President & CEO, Director at G1 Therapeutics, holds 549.67K shares in G1 Therapeutics (Ticker: GTHX). Most recently, John E. (Jack) Jr. Bailey Sold $7,662 shares of G1 Therapeutics on Jul 08, 2024 for an estimated value of 19.16K.
What is the percentage of profitable transactions made by John E. (Jack) Jr. Bailey?
The percentage of profitable transactions made by John E. (Jack) Jr. Bailey is 43%.
What is the average return per transaction made by John E. (Jack) Jr. Bailey?
The average return per transaction made by John E. (Jack) Jr. Bailey is -50.40%.
What stocks does John E. (Jack) Jr. Bailey hold?
John E. (Jack) Jr. Bailey holds: GTHX stocks.
What was John E. (Jack) Jr. Bailey’s latest transaction?
John E. (Jack) Jr. Bailey latest transaction was an Informative Sell of $19.16K.
What was John E. (Jack) Jr. Bailey's most profitable transaction?
John E. (Jack) Jr. Bailey’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2022. The return on the trade was 48.70%.
What is John E. (Jack) Jr. Bailey's role in G1 Therapeutics?
John E. (Jack) Jr. Bailey's role in G1 Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.